GSD (mm) what will be serum Beta-hCG? In 95%
percentile
|
5 1,026
iu/l
|
6 1,226/l
|
7 1,465/l
|
8 1,749/l
|
9 2,085
|
10 2,483
|
11 2,952
|
12 3,502
|
13 4,145
|
14 4,894
|
15 5,766
|
16 6,776
|
17 7,964
|
18
9,343
|
19 10,951
|
20 12,820
|
21 15,020
|
22 17,560
|
23 20,573
|
ECTOPIC
B hcg class in EP ,Progesterone value
< 9.4 mg/ml=ep,B hcg in serum is detectable if this is > 5mlu/ml. But not at urine unless serum
Beta HCG is >20 -25.HCG is secreted
from Syncititotrophoblasrs on day 5 to day -8 of implantation, & at
thIs stage the doubling time- After 7 weeks
time is high i.e.3.5
Surprisingly 30% of EP can show
normal rising B HCG. But in rest 70 % rise is slow and in some cases HCG may
remain plateau or even fall. Therefore abnormal B hcg is suspicious
but not conclusive. Fr EP . So only
serial mean titre can help in diag of EP about the exact diag.
Therefore EP can have NORMAL /rising
/ or even fall of B hcg below the expected value B hcg delay in rise (show)
Falling B hcg
UPT will be (+)-13 day after
Blood (+) 9 days after
Average of 3 CRL sacs (GSD)
TVS findings –From LMP
Pertaining to Menstrual week
4th M week =2 mm sac
5th M week=5 mm sac
6th m week=10 mm sac
7th m week=20 mm sac
8th m week=25mm sac
Vaginally sac can
be seen if serum
B hCG is > 1500 to 1000 but by TAS ( ABD Scan)
only if > 3000
Serum level of hCG:-from LMP of a
regular fertile cycle:-
16-23 days= 10-30 Iu
24-30 days= 30-100
31-38
days-10,000 to 160000
Day 35-day 45= 200-4000
2-3 m=12000-200000
12weeks=10000
Second tri= 24000-55000
3rd tri= 6000-48000
VIABILITY SCAN :-
Blighted ovem –
Gsd >8 mm but no anembryonic
pregnancy GSD >16 mm, no f.p. signs of failing IUP:- a)bradycardia in
relation to CRL, MSD
b)
CRL is < 5 mm i.e. oligoamnitic sac
c)
poor sac growth profile
d)large y. sac >5.6 mm priod to 10
weeks / abnormal y. sac
e) disappearance of CL
Human chorionic Gonadotropin
This so called pregnancy hormone is a
glycoprotein with biological activity similar to luteinizing hormone. Both act
via the same plasma membrane LH hCG receptor.
Source of HCG synthesis in preg
period: Although hCG is produced almost
exclusively in the placenta. Low levels are synthesized in the foetal kidneys .
Other fetal tissues produce either the B subunit or intact hCG molecule
Various malignant tumors alao produce
hCG sometimes in large amounts –especially trophoblastic neoplasms . Not impossible either:-!!!Chorionic
gonadotropin is in vey scant aount in the anterior pituitary gland. Nonetheless the
detection of hCG in blood or urine almost always indicates pregnancy.
Chemical Characteristics
Chorionic gonadotropin is a
glycoprotein with a molecular weight of 36,000 to 40,000 Da. It has the highest
carbohydrate content of any human hormone -30 percent. The carbohydrate
component and specially the terminal sialic acid , protects the molecule from
catabolism. The 36 hour plasma half life of intact hCG molecule is composed of
two dissimilar subunits termed a and b subunits. These are noncovalently linked
and are held together by electrostatic nd hydrophobic forces.
Isolated subunits are unable to bind the
LH-hCG receptor and thus lack biological activity.
This hormone is structurally related
to three other glycoprotein hormones –LH, FSH, and TSH. All four glycoproteins
share a common a subunits.
The B-subunits ,although sharing
certain similarities are characterized by distinctly different amino- acid
sequences. Recombination of an a and a B subunit of the four glycoprotein
hormones gives a molecule with biological activity characteristic of the
hormone from which the B- subunit was derived.
Biosynthesis
Syntheses of the alpha and beta –chains of hCG are regulated separately. A
single gene located on chromosome 6 encodes the a-subunit common to hCG,LH,FSH
andTSH . Seven genes on chromosome 19 encode for the B hCG and one for B-LH .
Both subunits are synthesized as larger precursors which are then cleaved by
endopeptidases. Intact hCG is then assembled and rapidly released by secretory
granule exocytosis. There are multiple forms of hCG in maternal plasma and
urine that vary enormously in bioactivity and immunoreactivity. Some result
from enzymatic degradation and other from modifications during molecular
synthesis and processing.
Before 5 weeks hCG is expressed in
both syncytiotrophoblast and cytotrophoblast . Later in the first trimester
when maternal serum levels peak hCG is produced almost solely in these
syncytiotrophonlast . At this time m RNA concentrations of both a and B
subunits in the syncytiotrophoblast are greater
than at term . This may be an important consideration when hCG is used
as a screening procedure to identify abnormal fetuses.
Different units & subunits make
Obstetricians confused as confused we are with PNDT Lc & CPA subclasses:-Circulating
free B-subunit levels are low to undetectable throughout pregnancy. In part
this is the result of its rate limiting synthesis. Free subunits that do not
combine with the B subunit are found in placental tissue and maternal plasma.
These levels increase gradually and steadily until they plateau at about 36
weeks gestation. At this time they account for 30 to 50 percent of hormone.
Thus a hCG secretion of complete hCG molecules is maximal at 8 to 10 weeks.
Concentrations of hCG in serum and
urine
The combined hCG molecule is plasma
of pregnant women 7 to 9 days after the midcycle surge of LH that precedes
ovulation. Thus hCG likely enters maternal blood at the time of blastocyst
implantation. Plasma levels increase rapidly doubling every 2 days in the first
trimester. Appreciable fluctuations in levels for a given patients are observed
on the same day evidence that trophoblast secretion of protein hormones is
episodic.
Intact hCG circulates as multiple
highly related isoforms with variable cross reactivity between commercial
assays. Thus there is considerable variation in calculated serum hCG levels
among the more than a hundred available assays . peak maternal plasma levels
reach approximately 100,000 mlU/mL between the 60th and 80 th days
after menses. At 10 to 12 weeks plasma levels begin to decline and a badir is
reached by approximately16 weeks . Plasma levels are maintained at this lower
level for the remainder of pregnancy .
The pattern of hCG appearance in
fetal blood is similar to that in the mother. Fetal plasma levels however are
only about 3 percent of those in maternal plasma . Amnionic fluid hCG
concentration early in pregnancy is similar to that in maternal plasma. As
pregnancy progresses hCG concentration in amnionic fluid declines and near term
the levels are approximately 20 percent of those in maternal plasma.
Maternal urine contains the same
variety of hCG degradation products as maternal plasma . The principal urinary
form is the terminal degradation hCG product the B-core fragment. Its
concentrations follow the same general pattern as that in maternal plasma
peaking at about 10 weeks. It is important to recognize that the so-called B
subunit antibody used in most pregnancy tests reacts with both intact hCG- the
major form in the plasma and with fragments of hCG – the major forms found in
urine.
Regulation of hCG synthesis and
clearance
Placental gonadotropin releasing is
likely involved in the regulation of hCG formation. Both GnRH and its receptor
are expressed by cytotrophoblasis and syncytiotrophoblast. GnRH administration
elevated circulating hCG levels and cultured trophoblast cells respond to GnRH
treatment with increased hCG secretion. Pituitary GnRH production also is
regulated by inhibin and Activin. In cultured placental cells Activin
stimulated and inhibin inhibits GnRH and hCG production.
Renal clearance of hCG accounts for
30 percent of its metabolic clearance. The remainder is likely cleared by
metabolism in the liver .Clearances of B and a- subunits are approximately 10- fold and 30-fold
respectively greater than that of intact hCG.
Biological Functions of hCG
Both hCG subunits are required for
binding to the LH-hCG receptors are present in various other tissues but their
role there is less defined. The best –known biological function of hCG is the
so called rescue and maintenance of corpus luteum function that is continued
progesterone production. Bradbury and colleagues found that the progesterone
producing life span of a corpus luteum of menstruation could be prolonged
perhaps for 2 weeks by hCG administration . This is only an incomplete
explanation for the physiological function of hCG in pregnancy. For example
maximum plasma hCG concentration are attained well after hCG stimulated corpus
luteum secretion of progesterone has ceased. Specifically progesterone luteal
synthesis begins to decline at about 6 weeks despite continued and increasing
hCG production.
No comments:
Post a Comment